Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vassilev

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Immunobiology|April 16, 2022
Induced antigen-binding polyreactivity in human serum IgAEkaterina N Gorshkova, Maxime Lecerf, Irina V Astrakhantseva, et al.
Blood|May 26, 1999
Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)T L Vassilev, M D Kazatchkine, J P Duong Van Huyen, et al.
Oncoimmunology|July 4, 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8<sup>+</sup> T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancerL Vassilev, T Ranki, T Joensuu, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Immunobiology|April 16, 2022
Induced antigen-binding polyreactivity in human serum IgAEkaterina N Gorshkova, Maxime Lecerf, Irina V Astrakhantseva, et al.
Blood|May 26, 1999
Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)T L Vassilev, M D Kazatchkine, J P Duong Van Huyen, et al.
Oncoimmunology|July 4, 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8<sup>+</sup> T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancerL Vassilev, T Ranki, T Joensuu, et al.
Pageof 5